Form 4: Sanara MedTech COO Jacob Waldrop Reports Tax Withholding Share Transaction
SEC Form 4
Chief Operating Officer Jacob A. Waldrop reports a transaction involving the withholding of Sanara MedTech Inc. common stock to cover tax obligations related to vested restricted stock.
Summary
- On April 15, 2025, Sanara MedTech Inc. withheld 378 shares of common stock from Jacob A. Waldrop, the company's Chief Operating Officer.
- This withholding was to satisfy tax obligations related to the vesting of 1,550 shares of restricted stock granted on April 15, 2024.
- The shares were withheld at a price of $29.38 per share.
- Following the transaction, Waldrop directly owns 11,513 shares of Sanara MedTech Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, with no inherent positive or negative implications for the company's performance.
Industry Context
This is a routine Form 4 filing related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 04/15/2024 | Date of grant of 1,550 shares of restricted stock to Jacob A. Waldrop. |
| 04/15/2025 | Date of transaction: 378 shares of common stock withheld for tax obligations. |
| 04/17/2025 | Date of signature on the Form 4 filing. |
Keywords
Sanara MedTech, SMTI, Jacob Waldrop, Chief Operating Officer, Form 4, Beneficial Ownership, Tax Withholding, Restricted Stock, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.